{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:55:58Z","timestamp":1786992958487,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jmoldx.2025.01.003","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T03:11:13Z","timestamp":1742958673000},"page":"306-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Deciphering Genomic Complexity of Multiple Myeloma Using Optimized Optical Genome Mapping"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4074-1623","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Guermouche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Roynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5428-1683","authenticated-orcid":false,"given":"Francesca","family":"Servoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Lestringant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Quilichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Terr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Defasque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Roche-Lestienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Penther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4574-3663","authenticated-orcid":false,"given":"Agn\u00e8s","family":"Daudignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2025.01.003_bib1","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1182\/blood-2015-06-650242","article-title":"Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?","volume":"126","author":"Chretien","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib2","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1038\/s41467-017-00638-w","article-title":"Expressed fusion gene landscape and its impact in multiple myeloma","volume":"8","author":"Cleynen","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41408-019-0199-3","article-title":"Deciphering the chronology of copy number alterations in multiple myeloma","volume":"9","author":"Aktas Samur","year":"2019","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100643","article-title":"The evolving role of translocation t(11;14) in the biology, prognosis, and management of multiple myeloma","volume":"41","author":"Paner","year":"2020","journal-title":"Blood Rev"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1182\/blood.2019004309","article-title":"Risk factors in multiple myeloma: is it time for a revision?","volume":"137","author":"Corre","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib6","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1200\/JCO.2008.20.6136","article-title":"Prognostic significance of copy-number alterations in multiple myeloma","volume":"27","author":"Avet-Loiseau","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib7","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-04-279596","article-title":"A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value","volume":"116","author":"Walker","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib8","doi-asserted-by":"crossref","first-page":"7776","DOI":"10.1158\/1078-0432.CCR-11-1791","article-title":"Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival","volume":"17","author":"Boyd","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib9","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1182\/blood-2018-10-880831","article-title":"High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma","volume":"133","author":"Thakurta","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bbmt.2019.12.726","article-title":"Outcome of multiple myeloma with chromosome 1q gain and 1p deletion after autologous hematopoietic stem cell transplantation: propensity score matched analysis","volume":"26","author":"Varma","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib11","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood.2022017863","article-title":"Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor","volume":"141","author":"Schavgoulidze","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib12","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: a report from International Myeloma Working Group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib13","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1200\/JCO.18.00776","article-title":"Development and validation of a cytogenetic prognostic index predicting survival in multiple myeloma","volume":"37","author":"Perrot","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib14","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1200\/JCO.21.02614","article-title":"Second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma: a European Myeloma Network (EMN) report within the HARMONY project","volume":"40","author":"D\u2019Agostino","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib15","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1038\/s41467-019-11680-1","article-title":"Genomic landscape and chronological reconstruction of driver events in multiple myeloma","volume":"10","author":"Maura","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib16","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1200\/JCO.23.01277","article-title":"Genomic classification and individualized prognosis in multiple myeloma","volume":"42","author":"Maura","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1158\/2643-3230.BCD-20-0132","article-title":"Revealing the impact of structural variants in multiple myeloma","volume":"1","author":"Rustad","year":"2020","journal-title":"Blood Cancer Discov"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib18","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3390\/genes11121453","article-title":"A tangle of genomic aberrations drives multiple myeloma and correlates with clinical aggressiveness of the disease: a comprehensive review from a biological perspective to clinical trial results","volume":"11","author":"Sessa","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib19","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13039-017-0327-3","article-title":"Combination of t(4;14), del(17p13), del(1p32) and 1q21 gain FISH probes identifies clonal heterogeneity and enhances the detection of adverse cytogenetic profiles in 233 newly diagnosed multiple myeloma","volume":"10","author":"Smol","year":"2017","journal-title":"Mol Cytogenet"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.72","article-title":"A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma","volume":"6","author":"Bolli","year":"2016","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semcdb.2021.04.014","article-title":"Chromothripsis as a pathogenic driver of multiple myeloma","volume":"123","author":"Maura","year":"2022","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib24","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41467-019-09555-6","article-title":"Multiple myeloma immunoglobulin lambda translocations portend poor prognosis","volume":"10","author":"Barwick","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2014.13","article-title":"Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients","volume":"4","author":"Walker","year":"2014","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib26","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cell.2013.03.021","article-title":"Punctuated evolution of prostate cancer genomes","volume":"153","author":"Baca","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93835-z","article-title":"Whole-genome optical mapping of bone-marrow myeloma cells reveals association of extramedullary multiple myeloma with chromosome 1 abnormalities","volume":"11","author":"Kriegova","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib28","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.3390\/cancers15194687","article-title":"Optical genome mapping reveals the complex genetic landscape of myeloma","volume":"15","author":"Gigu\u00e8re","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41408-024-01059-x","article-title":"A comprehensive approach to evaluate genetic abnormalities in multiple myeloma using optical genome mapping","volume":"14","author":"Zou","year":"2024","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib30","article-title":"Cytogenetics in the management of multiple myeloma: the guidelines from the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH)","volume":"71","author":"Daudignon","year":"2023","journal-title":"Curr Res Transl Med"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib31","article-title":"Cytogenetics in the management of hematological malignancies: an overview of alternative technologies for cytogenetic characterization","volume":"72","author":"Lestringant","year":"2024","journal-title":"Curr Res Transl Med"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib32","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/gcc.22977","article-title":"Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma","volume":"60","author":"Dalland","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib33","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1182\/blood-2012-12-471888","article-title":"Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells","volume":"121","author":"Walker","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib34","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood.2022016212","article-title":"The location of the t(4;14) translocation breakpoint within the NSD2 gene identifies a subset of patients with high-risk NDMM","volume":"141","author":"Stong","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib35","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1158\/1078-0432.CCR-22-3209","article-title":"Multiomic mapping of acquired chromosome 1 copy-number and structural variants to identify therapeutic vulnerabilities in multiple myeloma","volume":"29","author":"Boyle","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bax028","article-title":"GeneHancer: genome-wide integration of enhancers and target genes in GeneCards","volume":"2017","author":"Fishilevich","year":"2017","journal-title":"Database (Oxford)"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib37","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood.V98.10.3082","article-title":"Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors","volume":"98","author":"Avet-Loiseau","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2020.101145","article-title":"Reconstructing the evolutionary history of multiple myeloma","volume":"33","author":"Maura","year":"2020","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41375-018-0196-8","article-title":"A high-risk, double-hit, group of newly diagnosed myeloma identified by genomic analysis","volume":"33","author":"Walker","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fonc.2019.00234","article-title":"Recent advances in understanding FOXN3 in breast cancer, and other malignancies","volume":"9","author":"Kong","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib41","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1080\/10428194.2017.1283029","article-title":"Identification of a tumor suppressor network in T-cell leukemia","volume":"58","author":"Nagel","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib42","first-page":"1521","article-title":"Novel tumor-suppressor FOXN3 is downregulated in adult acute myeloid leukemia","volume":"18","author":"He","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1182\/blood.2023021221","article-title":"CAR T-cell therapy in multiple myeloma: mission accomplished?","volume":"143","author":"Rasche","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/14737140.2024.2343114","article-title":"Targeting GPRC5D in multiple myeloma","volume":"24","author":"Elemian","year":"2024","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib45","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood.2023022499","article-title":"BCMA- or GPRC5D-targeting bispecific antibodies in multiple myeloma: efficacy, safety, and resistance mechanisms","volume":"143","author":"Lee","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41408-023-00966-9","article-title":"GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review","volume":"14","author":"Rodriguez-Otero","year":"2024","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib47","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1038\/s41591-023-02491-5","article-title":"Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma","volume":"29","author":"Lee","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib48","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s43018-023-00625-9","article-title":"Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivation","volume":"4","author":"Derrien","year":"2023","journal-title":"Nat Cancer"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib49","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1182\/bloodadvances.2021004418","article-title":"Single- and double-hit events in genes encoding immune targets before and after T cell-engaging antibody therapy in MM","volume":"5","author":"Truger","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cancergen.2018.07.002","article-title":"Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: an evidence-based review from the Cancer Genomics Consortium working group for plasma cell disorders","volume":"228-229","author":"Pugh","year":"2018","journal-title":"Cancer Genet"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib51","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1038\/s41375-018-0037-9","article-title":"Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups","volume":"32","author":"Bolli","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib52","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/leu.2017.179","article-title":"Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients","volume":"32","author":"Shah","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib53","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.semcdb.2021.01.004","article-title":"Chromoanagenesis, the mechanisms of a genomic chaos","volume":"123","author":"Pellestor","year":"2022","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib54","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1182\/blood-2011-03-344069","article-title":"Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients","volume":"118","author":"Magrangeas","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2025.01.003_bib55","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.leukres.2018.12.005","article-title":"Clinical impact of chromothriptic complex chromosomal rearrangements in newly diagnosed multiple myeloma","volume":"76","author":"Kaur","year":"2019","journal-title":"Leuk Res"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157825000352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157825000352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:42:50Z","timestamp":1775022170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157825000352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1525157825000352"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2025.01.003","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering Genomic Complexity of Multiple Myeloma Using Optimized Optical Genome Mapping","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2025.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}